Aernoud Fiolet
183 The efficacy and safety of low-dose colchicine in patients with coronary disease Figure 2. Myocardial infarction, stroke, and coronary revascularization. Pooled relative risks and 95% confidence intervals for the individual components of the composite endpoints in patients treated with colchicine as compared with placebo or no colchicine. CI, confidence interval; GIV, generic inverse variance.
Made with FlippingBook
RkJQdWJsaXNoZXIy ODAyMDc0